Pharmaceutical Business review is using cookies

ContinueLearn More
Close
December 10, 2018

AstraZeneca’s Imfinzi fails to improve OS in head and neck cancer trial

AstraZeneca said that the combination of its Imfinzi (durvalumab) monotherapy and tremelimumab has failed to improve overall survival (OS) rate compared to standard-of-care (SoC) chemotherapy in a head and neck cancer trial.

Continue
Image: AstraZeneca’s Imfinzi has failed to improve OS in head and neck cancer trial. Photo: courtesy of AstraZeneca.
December 6, 2018

Biopharmaceutical firm UCB to invest £1bn in UK for research and development

Image: The UK has announced an investment of more than £1.3bn to advance healthcare innovation. Photo: courtesy of BlackJack3D / iStock.
December 5, 2018

J&J’s Darzalex reduces disease progression in multiple myeloma study

Image: Johnson & Johnson headquarters in New Brunswick, New Jersey. Photo: courtesy of Ekem.

Contracts

December 5, 2018

Ixico secures expanded contract from major biopharmaceutical firm

Image: Ixico has secured expanded contract from major biopharmaceutical firm. Photo: courtesy of rawpixel / Unsplash.

hVIVO signs new contracts with global biopharmaceutical firm

Opiant signs contract with BARDA to accelerate OPTN003 product development

BioCryst bags contract to supply RAPIVAB antiviral flu therapy doses to CDC

Deals

Deals December 7, 2018

AstraZeneca divests asthma and rhinitis drug rights to Covis Pharma

Pharmaceutical Business Review

GSK to buy oncology-focused biopharmaceutical firm Tesaro for $5.1bn

Roche’s Genentech agrees to buy Jecure Therapeutics

EC approves Takeda’s $62bn acquisition of Shire

Popular

  1. French pharma firm Cristers selects Adents Prodigi cloud serialization solution
  2. Eisai, UCL to launch phase I trials of E2814 for Alzheimer’s disease
  3. Tris Pharma recalls infants’ liquid Ibuprofen in US
  4. Novartis initiates phase III trials of ligelizumab in urticaria
  5. Momenta revises regulatory strategy for proposed Humira biosimilar

PRESS RELEASES

Webinar: Optimising Metal Powder Properties for Manufacturing Processes
Webinar: Optimising Metal Powder Properties for Manufacturing Processes
Seminar: Malvern Panalytical Live
Seminar: Malvern Panalytical Live
Webinar: Demo at Your Desk Spraytec
Webinar: Demo at Your Desk Spraytec
Webinar: A Simple Alternative to ICP-MS for Elemental Impurity Analysis
Webinar: A Simple Alternative to ICP-MS for Elemental Impurity Analysis
Webinar: Rheological Assessment of Particle Size on Cohesive Strength of Powders
Webinar: Rheological Assessment of Particle Size on Cohesive Strength of Powders

Suppliers

Whitepapers

Analysis of Ultra-Low Sulphur Fuels
Analysis of Ultra-Low Sulphur Fuels
Combating Counterfeit Drugs
Combating Counterfeit Drugs
The Value of Winning the Talent War and Investing in Education
The Value of Winning the Talent War and Investing in Education